SourcesAnwar, Mehruba; Law, Royal; Schier, Josh. “Notes from the Field. Kratom (Mitragyna speciosa) exposures reported to poison centers — United States, 2010–2015.” CDC Morbidity and Mortality Weekly Reports, July 29, 2016. Accessed August 7, 2019.
Buresh, Megan. “Treatment of kratom dependence with buprenorphine-naloxone maintenance.” Journal of Addiction Medicine, November-December 2018. Accessed August 7, 2019.
Food and Drug Administration (FDA). “Laboratory analysis of kratom products for heavy metals.” April 3, 2019. Accessed August 7, 2019.
Fluyau, Dimy; Revadigar, Neelambika. “Biochemical benefits, diagnosis, and clinical risks evaluation of kratom.” Frontiers in Psychiatry, April 24, 2017. Accessed August 7, 2019.
Galbis-Reig, David. “A case report of kratom addiction and withdrawal.” Wisconsin Medical Journal, February 2016. Accessed August 7, 2019.
LaBryer, Lauren; Sharma, Rohan; Chaudhari, Kaustubh; et al. “Kratom, an emerging drug of abuse, raises prolactin and causes secondary hypogonadism: Case report.” Journal of Investigative Medicine, High Impact Case Reports, March 16, 2018. Accessed August 7, 2019.
Leow, Cynthia. “Kratom.” Texas Tech University Infant Risk Center, 2019. Accessed August 7, 2019.
Lu, Jun; Wei, Heming; Wu, Jianjun; et al. “Evaluation of the cardiotoxicity of mitragynine and its analogues using human induced pluripotent stem cell-derived cardiomyocytes.” PLoS One, December 2014. Accessed August 7, 2019.
National Institutes of Health, National Center for Complementary and Integrative Health. “In the news: Kratom (Mitragyna speciosa).” June 29, 2018. Accessed August 7, 2019.
Olsen, Emily; O’Donnell, Julie; Mattson, Christine; et al. “Notes from the field: Unintentional drug overdose deaths with kratom detected — 27 States, July 2016–December 2017.” CDC Morbidity and Mortality Weekly Reports, April 12, 2019. Accessed August 7, 2019.
Prozialeck, Walter; Avery, Bonnie; Boyer, Edward; et al. “Kratom policy: The challenge of balancing therapeutic potential with public safety.” International Journal of Drug Policy, August 2019. Accessed August 7, 2019.
Smith, Kirsten; Lawson, Thomas. “Prevalence and motivations for kratom use in a sample of substance users enrolled in a residential treatment program.” Drug and Alcohol Dependence, September 2017, Accessed August 7, 2019.
Substance Abuse and Mental Health Services Administration (SAMHSA). “Urgent and emerging issues in prevention: Marijuana, kratom, e-cigarettes.” 2019. Accessed August 7, 2019.
Tayabali, Khadija; Bolzon, Colin; Foster, Paul; et al. “Kratom: A dangerous player in the opioid crisis.” Journal of Community Hospital Internal Medicine Perspectives, June 12, 2018. Accessed August 7, 2019.
Van Velzer, Ryan. “South Florida’s kratom cocktail bars may see herbal drug outlawed.” South Florida Sun Sentinel, December 1, 2017. Accessed August 7, 2019.